Atelosteogenesis type I
Atelosteogenesis Type I[edit | edit source]
Atelosteogenesis Type I is a rare genetic disorder characterized by skeletal abnormalities. It is one of the types of atelosteogenesis, which are a group of disorders that affect bone development. Atelosteogenesis Type I is inherited in an autosomal dominant pattern, meaning that only one copy of the altered gene is sufficient to cause the disorder.
Clinical Features[edit | edit source]
Individuals with Atelosteogenesis Type I typically present with severe skeletal dysplasia. The clinical features include:
- Short limbs (rhizomelic shortening)
- Narrow chest
- Abnormalities of the spine
- Cleft palate
- Clubfoot
These features are usually apparent at birth or during prenatal ultrasound examinations.
Genetic Basis[edit | edit source]
Atelosteogenesis Type I is caused by mutations in the FLNB gene, which provides instructions for making a protein called filamin B. This protein is involved in the development and maintenance of the cytoskeleton, which is the structural framework that helps cells maintain their shape and internal organization.
Diagnosis[edit | edit source]
Diagnosis of Atelosteogenesis Type I is based on clinical evaluation, radiographic findings, and genetic testing. Prenatal diagnosis may be possible through ultrasound and genetic testing if there is a known family history of the disorder.
Management[edit | edit source]
There is no cure for Atelosteogenesis Type I, and management is primarily supportive. Treatment may involve:
- Orthopedic surgery to address skeletal abnormalities
- Respiratory support due to chest abnormalities
- Physical therapy to improve mobility
Prognosis[edit | edit source]
The prognosis for individuals with Atelosteogenesis Type I is generally poor. Many affected individuals do not survive past infancy due to respiratory complications. However, the severity of the condition can vary, and some individuals may live longer with appropriate medical care.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD